Aggrenox Prevention of Access Stenosis

NCT00067119 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

649

Enrollment

NIH

Sponsor class

Conditions

Kidney Failure

Interventions

DRUG: Aggrenox
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]